Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TTR Cardiac Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03458130
What this trial is testing

Study of AG10 in Amyloid Cardiomyopathy

Who this might be right for
Familial ATTR-CM (ATTRm-CM, or FAC)Wild-type ATTR-CM (ATTRwt-CM)
Eidos Therapeutics, a BridgeBio company 49
Not applicableLooking for participantsNCT07112066
What this trial is testing

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

Who this might be right for
Amyloidosis Cardiac
Dominik Benz 50
Very early researchLooking for participantsNCT06082050
What this trial is testing

Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy

Who this might be right for
Transthyroxin Amyloidosis Cardiomyopathy
Zhejiang University 7
Not applicableActive Not RecruitingNCT07494656
What this trial is testing

A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

Who this might be right for
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Pfizer 1
Large-scale testing (Phase 3)Looking for participantsNCT07207811
What this trial is testing

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S 1,280
Not applicableUnknownNCT05814380
What this trial is testing

The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.

Who this might be right for
Transthyretin Amyloidosis
Katarzyna Holcman 100
Not applicableEnrolling By InvitationNCT07238426
What this trial is testing

ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

Who this might be right for
Cardiac AmyloidosisTransthyretin Amyloidosis
Kotyora Family Medicine Health Management and Education Association 800
Not applicableLooking for participantsNCT04535349
What this trial is testing

Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

Who this might be right for
Amyloidosis Transthyretin
University Hospital, Caen 35
Not applicableLooking for participantsNCT06907836
What this trial is testing

Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine

Who this might be right for
Cardiac Amyloidosis
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)Study completedNCT04136171
What this trial is testing

CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Who this might be right for
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Ionis Pharmaceuticals, Inc. 1,438
Not applicableActive Not RecruitingNCT07062848
What this trial is testing

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Yale University 1,500,000
Not applicableUnknownNCT04985734
What this trial is testing

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy

Who this might be right for
Amyloidosis CardiacAmyloid PolyneuropathyAmyloidosis+3 more
University Hospital, Antwerp 200
Not applicableNo Longer AvailableNCT05505838
What this trial is testing

Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin-mediated Amyloidosis With CardiomyopathyATTR Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
Very early researchStudy completedNCT05023889
What this trial is testing

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

Who this might be right for
PolyneuropathiesWild Type ATTR AmyloidosisWild-Type Transthyretin-Related (ATTR)Amyloidosis+2 more
Austin Neuromuscular Center 10
Not applicableStudy completedNCT06029452
What this trial is testing

A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).

Who this might be right for
ATTR-CM
Pfizer 558
Not applicableLooking for participantsNCT07654855
What this trial is testing

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

Who this might be right for
Transthyretin AmyloidosisTransthyretin Amyloidosis With CardiomyopathyTransthyretin Amyloidosis With Polyneuropathy
AstraZeneca 320
Post-approval studies (Phase 4)UnknownNCT04963985
What this trial is testing

The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients

Who this might be right for
Transthyretin Amyloidosis
Peking University Third Hospital 10
Large-scale testing (Phase 3)Study completedNCT06788535
What this trial is testing

REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

Who this might be right for
Cardiac Amyloidosis
Sharmila Dorbala 204
Not applicableActive Not RecruitingNCT06651073
What this trial is testing

ATTR-CM: A Multi-country, Non-interventional Disease Registry

Who this might be right for
Transthyretin Amyloid Cardiopathy
Pfizer 350
Post-approval studies (Phase 4)Study completedNCT05633563
What this trial is testing

The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

Who this might be right for
Transthyretin Amyloid CardiopathyMitochondrial Pathology
Steen Hvitfeldt Poulsen 24
Next Page